ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Cetuximab Plus Cisplatin in Treating Patients With Metastatic or Recurrent Cancer of the Head and Neck That Has Not Responded to Cisplatin Chemotherapy

This study is ongoing, but not recruiting participants.
Study NCT00004865.   Last updated on July 23, 2008.   Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:
1 Conditions listed in this trial
Head and Neck Cancer
2 Additional conditions recognized in this trial
Head and Neck Neoplasms
3 More general conditions related to this trial
Neoplasms
Neoplasms by Site
4 Interventions listed in this trial
cetuximab
cisplatin
fluorouracil
paclitaxel
5 More general drug interventions related to this trial
Antimetabolites
Antimetabolites, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Tubulin Modulators
6 Sponsors listed in this trial
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)




Links to all studies - primarily for crawlers